AD

Prof Sean Hood and Mr Bradley Roberts

Pharmacogenetic screening to optimise antidepressant drug therapies in young people

Researchers at the Perron Institute are exploring the benefits of pharmacogenetic testing to optimise antidepressant therapy.

Pharmacogenetic screening to optimise antidepressant drug therapies in young people

Subscribe to continue reading

Log in or create an account to access the full article.

AD